The administration of CoQ10 as an antioxidant had no significant effect on biomarkers associated with amyloid and tau pathology in AD measured in CSF (Aβ42, tau, and P-tau), nor on cognitive function [135]. Here, MAPT is linked to Alzheimer disease.